762 related articles for article (PubMed ID: 12377952)
1. Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways.
Nagy ZS; Wang Y; Erwin-Cohen RA; Aradi J; Monia B; Wang LH; Stepkowski SM; Rui H; Kirken RA
J Leukoc Biol; 2002 Oct; 72(4):819-28. PubMed ID: 12377952
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway.
Beadling C; Ng J; Babbage JW; Cantrell DA
EMBO J; 1996 Apr; 15(8):1902-13. PubMed ID: 8617237
[TBL] [Abstract][Full Text] [Related]
3. IL-2 and IL-7 induce heterodimerization of STAT5 isoforms in human peripheral blood T lymphoblasts.
Rosenthal LA; Winestock KD; Finbloom DS
Cell Immunol; 1997 Nov; 181(2):172-81. PubMed ID: 9398404
[TBL] [Abstract][Full Text] [Related]
4. IL-2 and long-term T cell activation induce physical and functional interaction between STAT5 and ETS transcription factors in human T cells.
Rameil P; Lécine P; Ghysdael J; Gouilleux F; Kahn-Perlès B; Imbert J
Oncogene; 2000 Apr; 19(17):2086-97. PubMed ID: 10815800
[TBL] [Abstract][Full Text] [Related]
5. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
[TBL] [Abstract][Full Text] [Related]
6. IL-4 selectively inhibits IL-2-triggered Stat5 activation, but not proliferation, in human T cells.
Castro A; Sengupta TK; Ruiz DC; Yang E; Ivashkiv LB
J Immunol; 1999 Feb; 162(3):1261-9. PubMed ID: 9973378
[TBL] [Abstract][Full Text] [Related]
7. Differential control of the phosphorylation state of proline-juxtaposed serine residues Ser725 of Stat5a and Ser730 of Stat5b in prolactin-sensitive cells.
Yamashita H; Xu J; Erwin RA; Farrar WL; Kirken RA; Rui H
J Biol Chem; 1998 Nov; 273(46):30218-24. PubMed ID: 9804779
[TBL] [Abstract][Full Text] [Related]
8. Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.
Kuroki M; O'Flaherty JT
Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):691-6. PubMed ID: 10417333
[TBL] [Abstract][Full Text] [Related]
9. Regulation of IL-6 signaling by p53: STAT3- and STAT5-masking in p53-Val135-containing human hepatoma Hep3B cell lines.
Rayanade RJ; Ndubuisi MI; Etlinger JD; Sehgal PB
J Immunol; 1998 Jul; 161(1):325-34. PubMed ID: 9647240
[TBL] [Abstract][Full Text] [Related]
10. Rapid activation of C-Raf-1 after stimulation of the T-cell receptor or the muscarinic receptor type 1 in resting T cells.
Siegel JN; June CH; Yamada H; Rapp UR; Samelson LE
J Immunol; 1993 Oct; 151(8):4116-27. PubMed ID: 8409389
[TBL] [Abstract][Full Text] [Related]
11. Immunoreactivity of Stat5 phosphorylated on tyrosine as a cell-based measure of Bcr/Abl kinase activity.
Jacobberger JW; Sramkoski RM; Frisa PS; Ye PP; Gottlieb MA; Hedley DW; Shankey TV; Smith BL; Paniagua M; Goolsby CL
Cytometry A; 2003 Aug; 54(2):75-88. PubMed ID: 12879454
[TBL] [Abstract][Full Text] [Related]
12. Cutting edge: TCR stimulation by antibody and bacterial superantigen induces Stat3 activation in human T cells.
Gerwien J; Nielsen M; Labuda T; Nissen MH; Svejgaard A; Geisler C; Röpke C; Odum N
J Immunol; 1999 Aug; 163(4):1742-5. PubMed ID: 10438903
[TBL] [Abstract][Full Text] [Related]
13. Delineation and mapping of Stat5 isoforms activated by granulocyte colony-stimulating factor in myeloid cells.
Chakraborty A; Dyer KF; Tweardy DJ
Blood Cells Mol Dis; 2000 Aug; 26(4):320-30. PubMed ID: 11042034
[TBL] [Abstract][Full Text] [Related]
14. Characterization of STAT5B phosphorylation correlating with expression of cytokine-inducible SH2-containing protein (CIS).
Cooper JC; Boustead JN; Yu CL
Cell Signal; 2006 Jun; 18(6):851-60. PubMed ID: 16125365
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 2 and 15 activate Stat3alpha in human T lymphocytes.
Nielsen M; Nordahl M; Svejgaard A; Odum N
Cytokine; 1998 Oct; 10(10):735-8. PubMed ID: 9811525
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-9 (IL-9) induces cell growth arrest associated with sustained signal transducer and activator of transcription activation in lymphoma cells overexpressing the IL-9 receptor.
Demoulin JB; Van Snick J; Renauld JC
Cell Growth Differ; 2001 Mar; 12(3):169-74. PubMed ID: 11306517
[TBL] [Abstract][Full Text] [Related]
17. IL-2-mediated cell cycle progression and inhibition of apoptosis does not require NF-kappa B or activating protein-1 activation in primary human T cells.
Iacobelli M; Rohwer F; Shanahan P; Quiroz JA; McGuire KL
J Immunol; 1999 Mar; 162(6):3308-15. PubMed ID: 10092783
[TBL] [Abstract][Full Text] [Related]
18. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL
J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040
[TBL] [Abstract][Full Text] [Related]
19. {beta}1 Integrin and IL-3R coordinately regulate STAT5 activation and anchorage-dependent proliferation.
Defilippi P; Rosso A; Dentelli P; Calvi C; Garbarino G; Tarone G; Pegoraro L; Brizzi MF
J Cell Biol; 2005 Mar; 168(7):1099-108. PubMed ID: 15795318
[TBL] [Abstract][Full Text] [Related]
20. STAT5A interacts with and is phosphorylated upon activation of the mu-opioid receptor.
Mazarakou G; Georgoussi Z
J Neurochem; 2005 May; 93(4):918-31. PubMed ID: 15857395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
